Pharmaceuticals Industry Market Index
The Pharmaceuticals Industry in the Health Care Sector includes companies engaged in the research, development, or production of pharmaceuticals (including veterinary drugs).
The Pharmaceuticals industry index is a market composite index that includes 16 stocks from public trading companies and ADRs with the largest market capitalizations in the Pharmaceuticals industry.
The list of stocks in the Pharmaceuticals industry includes Embecta Corp, Zoetis Inc, Viatris Inc., Pfizer Inc, Eli Lilly and Co, Sanofi, Novartis AG, Astrazeneca PLC, Glaxosmithkline PLC, Roche Holding AG, Merck & Co Inc, Bristol-Myers Squibb Co, Catalent Inc, Johnson & Johnson, Novo Nordisk A/S and Roche Holding AG.
12/6/2023 11:51 Health Care Sector Pharmaceuticals Industry
$19,434
Change: -0.23%
Open: $19,512
High: $19,572
Low: $19,334
| Embecta Corp (EMBC) |
+1.61%
|
| Zoetis Inc (ZTS) |
+1.43%
|
| Viatris Inc. (VTRS) |
+1.20%
|
| Pfizer Inc (PFE) |
+0.55%
|
| Eli Lilly and Co (LLY) |
+0.33%
|
| Sanofi (SNY) |
+0.21%
|
| Novartis AG (NVS) |
+0.08%
|
| Astrazeneca PLC (AZN) |
+0.06%
|
| Glaxosmithkline PLC (GSK) |
-0.14%
|
| Pharmaceuticals Industry |
-0.23%
|
| Roche Holding AG (RHHBY) |
-0.36%
|
| Merck & Co Inc (MRK) |
-0.46%
|
| Bristol-Myers Squibb Co (BMY) |
-0.50%
|
| Catalent Inc (CTLT) |
-0.51%
|
| Johnson & Johnson (JNJ) |
-0.95%
|
| Novo Nordisk A/S (NVO) |
-1.43%
|
| Roche Holding AG (RHHBF) |
-1.79%
|
Index Value: $19,434 -0.23%
Volume: 705.73M Average Volume (3 month): 2.35B
Market Capitalization: $50.41T
EBITDA: $6.36T
PEG Ratio (5 year Expected): 17.93
Dividend Yield: 3.31%
Dividend Rate: $645.76
Dividend Yield (Forward): 2.39%
Dividend Rate (Forward): $464.43
Shares Outstanding: 709.14B
Book Value: $4,750
Short Ratio: 1.78
Price Target (1 year): $22,417
Volume: 705.73M Average Volume (3 month): 2.35B
Market Capitalization: $50.41T
EBITDA: $6.36T
PEG Ratio (5 year Expected): 17.93
Dividend Yield: 3.31%
Dividend Rate: $645.76
Dividend Yield (Forward): 2.39%
Dividend Rate (Forward): $464.43
Shares Outstanding: 709.14B
Book Value: $4,750
Short Ratio: 1.78
Price Target (1 year): $22,417
| Symbol | Security | Price | Gain | Volume | vol. Str. | Weight |
| EMBC | Embecta Corp | 18.35 | +1.61% | 45,963 | 0.19 | 0.04% |
| ZTS | Zoetis Inc | 182.22 | +1.43% | 388,432 | 0.52 | 3.30% |
| VTRS | Viatris Inc. | 9.72 | +1.20% | 2.17M | 0.58 | 0.46% |
| PFE | Pfizer Inc | 29.25 | +0.55% | 9.29M | 0.74 | 6.58% |
| LLY | Eli Lilly and Co | 590.12 | +0.33% | 781,184 | 0.58 | 22.36% |
| SNY | Sanofi | 46.44 | +0.21% | 401,983 | 0.48 | 4.65% |
| NVS | Novartis AG | 97.05 | +0.08% | 625,941 | 1.03 | 7.74% |
| AZN | Astrazeneca PLC | 64.05 | +0.06% | 1.69M | 0.75 | 7.95% |
| GSK | Glaxosmithkline PLC | 36.28 | -0.14% | 930,095 | 0.62 | 2.95% |
| Pharmaceuticals Industry | 19,434.38 | -0.23% | 705.73M | 0.74 | 41.65% | |
| RHHBY | Roche Holding AG | 35.73 | -0.36% | 1.78M | 1.86 | 0.01% |
| MRK | Merck & Co Inc | 105.74 | -0.46% | 2.25M | 0.77 | 10.78% |
| BMY | Bristol-Myers Squibb Co | 49.98 | -0.50% | 4.60M | 0.86 | 4.09% |
| CTLT | Catalent Inc | 38.71 | -0.51% | 221,175 | 0.23 | 0.28% |
| JNJ | Johnson & Johnson | 157.04 | -0.95% | 1.83M | 0.65 | 15.29% |
| NVO | Novo Nordisk A/S | 98.21 | -1.43% | 1.64M | 0.84 | 13.51% |
| RHHBF | Roche Holding AG | 302.00 | -1.79% | 11 | 0.10 | 0.00% |
| Symbol | Security | Market Cap | Div Yield | PEG Ratio |
| EMBC | Embecta Corp | 1.004B | 3.45% | |
| ZTS | Zoetis Inc | 81.249B | 0.81% | 3.16 |
| VTRS | Viatris Inc. | 10.965B | 5.14% | -1.27 |
| PFE | Pfizer Inc | 167.642B | 5.41% | -1.56 |
| LLY | Eli Lilly and Co | 561.61B | 0.74% | 3.10 |
| SNY | Sanofi | 117.816B | 0.85 | |
| NVS | Novartis AG | 199.38B | 3.54% | 1.95 |
| AZN | Astrazeneca PLC | 196.61B | 4.56% | 1.33 |
| GSK | Glaxosmithkline PLC | 73.026B | 1.57% | 1.89 |
| Pharmaceuticals Industry | $50.41T | 3.31% | 17.93 | |
| RHHBY | Roche Holding AG | 217.22B | 28.47% | |
| MRK | Merck & Co Inc | 253.858B | 2.84% | 7.31 |
| BMY | Bristol-Myers Squibb Co | 99.54B | 4.65% | -25.96 |
| CTLT | Catalent Inc | 7.114B | 2.17 | |
| JNJ | Johnson & Johnson | 365.016B | 3.07% | 2.88 |
| NVO | Novo Nordisk A/S | 456.596B | 6.81% | 95.99 |
| RHHBF | Roche Holding AG | 212.019B | 3.33% | |
Back to Market Summary